SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-May-23 4:07 PM View: | Endra Life Sciences Inc. (NDRA) | 02-May-23 | Purchase | 83,333 | $1.20 | $99,999.60 | 436% 19.1K to 102.43K | |
23-Jul-20 8:00 AM View: | Endra Life Sciences Inc. (NDRA) | 21-Jul-20 | Exercise (in-the money or at-the-money) | 100,503 | $0.87 | $87,437.60 | 36% 281.51K to 382.01K | |
09-Jun-20 7:27 AM View: | Endra Life Sciences Inc. (NDRA) | 08-Jun-20 | Market Purchase | 5,000 | $0.92 | $4,600.00 | 2% 276.51K to 281.51K | (18%) |
29-May-20 6:49 AM View: | Endra Life Sciences Inc. (NDRA) | 28-May-20 | Market Purchase | 5,000 | $0.90 | $4,500.00 | 2% 271.51K to 276.51K | (16%) |
26-May-20 7:03 AM View: | Endra Life Sciences Inc. (NDRA) | 22-May-20 | Market Purchase | 10,000 | $0.78 | $7,800.00 | 4% 242.08K to 252.08K | (3%) |
13-Apr-20 4:42 PM View: | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 42,857 | -- | -- | 22% 199.23K to 242.08K | |
11-Dec-19 5:48 PM View: | Endra Life Sciences Inc. (NDRA) | 11-Dec-19 | Grant | 100,503 | $0.87 | $87,437.60 | 102% 98.72K to 199.23K | (12%) |
06-Dec-19 5:26 PM View: | Provention Bio, Inc. (PRVB) | 03-Dec-19 | Acquisition (other) | 342,000 | -- | -- | 191% 178.71K to 520.71K | |
30-Sep-19 5:00 PM View: | Provention Bio, Inc. (PRVB) | 30-Sep-19 | Market Purchase | 30,000 | $6.83 | $204,900.00 | 20% 148.71K to 178.71K | 11% |
26-Sep-19 6:08 PM View: | Provention Bio, Inc. (PRVB) | 26-Sep-19 | Market Purchase | 5,000 | $8.44 | $42,200.00 | 3% 143.71K to 148.71K | (10%) |
25-Sep-19 5:45 PM View: | Provention Bio, Inc. (PRVB) | 25-Sep-19 | Market Purchase | 5,000 | $8.39 | $41,950.00 | 4% 138.71K to 143.71K | (10%) |
09-Aug-19 6:01 AM View: | Provention Bio, Inc. (PRVB) | 08-Aug-19 | Market Purchase | 10,000 | $9.09 | $90,900.00 | 8% 128.71K to 138.71K | (17%) |
20-Jun-19 5:37 PM View: | Provention Bio, Inc. (PRVB) | 20-Jun-19 | Market Purchase | 10,000 | $10.96 | $109,600.00 | 8% 118.71K to 128.71K | (31%) |
18-Jun-19 9:00 PM View: | Provention Bio, Inc. (PRVB) | 18-Jun-19 | Market Purchase | 10,000 | $10.88 | $108,800.00 | 9% 108.71K to 118.71K | (30%) |
17-Jun-19 6:00 PM View: | Provention Bio, Inc. (PRVB) | 17-Jun-19 | Market Purchase | 25,000 | $12.16 | $304,000.00 | 30% 83.71K to 108.71K | (38%) |
02-Jan-19 4:18 PM View: | Cue Biopharma, Inc. (CUE) | 28-Dec-18 | Market Purchase | 7,000 | $4.62 | $32,340.00 | 14% 50.0K to 57.0K | 183% |
31-Dec-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 28-Dec-18 | Market Purchase | 10,000 | $1.76 | $17,600.00 | 14% 73.71K to 83.71K | 329% |
28-Dec-18 8:40 AM View: | Cue Biopharma, Inc. (CUE) | 27-Dec-18 | Market Purchase | 20,000 | $4.77 | $95,400.00 | 67% 30.0K to 50.0K | 174% |
28-Dec-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 27-Dec-18 | Market Purchase | 20,000 | $1.95 | $39,000.00 | 37% 53.71K to 73.71K | 287% |
04-Jan-19 6:21 PM View: | Cue Biopharma, Inc. (CUE) | 24-Dec-18 | Market Purchase | 10,000 | $4.81 | $48,100.00 | 50% 20.0K to 30.0K | 172% |
27-Dec-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 24-Dec-18 | Market Purchase | 17,270 | $1.92 | $33,158.40 | 47% 36.44K to 53.71K | 293% |
26-Dec-18 4:07 PM View: | Cue Biopharma, Inc. (CUE) | 21-Dec-18 | Market Purchase | 10,000 | $4.49 | $44,900.00 | 100% 10.0K to 20.0K | 191% |
26-Dec-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 21-Dec-18 | Market Purchase | 2,000 | $1.85 | $3,700.00 | 6% 34.44K to 36.44K | 308% |
21-Dec-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 20-Dec-18 | Purchase | 5,000 | $1.96 | $9,800.00 | 17% 29.44K to 34.44K | |
18-Dec-18 4:31 PM View: | Cue Biopharma, Inc. (CUE) | 17-Dec-18 | Purchase | 10,000 | $5.48 | $54,800.00 | 100% 0 to 10.0K | |
06-Dec-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 03-Dec-18 | Purchase | 4,442 | $2.45 | $10,882.90 | 18% 25.0K to 29.44K | |
03-Dec-18 7:13 PM View: | Provention Bio, Inc. (PRVB) | 30-Nov-18 | Purchase | 4,849 | $2.45 | $11,880.00 | 24% 20.15K to 25.0K | |
03-Dec-18 7:13 PM View: | Provention Bio, Inc. (PRVB) | 29-Nov-18 | Purchase | 151 | $2.47 | $372.97 | < 1% 20.0K to 20.15K | |
28-Nov-18 6:11 PM View: | Provention Bio, Inc. (PRVB) | 27-Nov-18 | Purchase | 10,000 | $2.46 | $24,600.00 | 100% 10.0K to 20.0K | |
27-Nov-18 6:00 PM View: | Provention Bio, Inc. (PRVB) | 26-Nov-18 | Purchase | 10,000 | $2.65 | $26,500.00 | 100% 0 to 10.0K | |
15-Nov-18 4:16 PM View: | Endra Life Sciences Inc. (NDRA) | 13-Nov-18 | Conversion | 59,524 | $1.68 | $100,000.00 | 102% 58.63K to 118.15K | |
19-May-17 4:07 PM View: | Endra Life Sciences Inc. (NDRA) | 12-May-17 | Conversion | 19,426 | $1.40 | $27,196.40 | 50% 39.2K to 58.63K | |
28-Aug-12 5:11 PM View: | XELR8 Holdings, Inc. (CHUC) | 27-Aug-12 | Acquisition (other) | 200,000 | -- | -- | 17% 1.17M to 1.37M | |
09-Apr-12 5:11 PM View: | XELR8 Holdings, Inc. (CHUC) | 09-Apr-12 | Grant | 1,000,000 | $0.06 | $60,000.00 | 595% 168.13K to 1.17M | |
01-Mar-12 3:48 PM View: | XELR8 Holdings, Inc. (CHUC) | 14-Nov-11 | Grant | 62,500 | $0.04 | $2,500.00 | 59% 105.63K to 168.13K | (84%) |
01-Mar-12 3:48 PM View: | XELR8 Holdings, Inc. (CHUC) | 10-Aug-11 | Grant | 38,832 | $0.14 | $5,436.48 | 58% 66.8K to 105.63K | (95%) |
11-Jan-05 4:13 PM View: | Medivation, Inc. (MDVN) | 17-Dec-04 | Market Purchase | 35,004 | $1.55 | $54,256.20 | 31% 113.28K to 148.29K | 10190% |